✦ LIBER ✦

Attainment of Dual Treatment Levels for High-Sensitivity C-Reactive Protein and Lipids in Older (>65 Years) Patients with Cardiovascular Disease Risk: Ezetimibe/Simvastatin Versus Atorvastatin

✍ Scribed by Franklin Joseph Zieve; W. Virgil Brown; JoAnne M. Foody; Charlotte Jones-Burton; Qian Dong; Joanne F. Tomassini; Arvind Shah; Andrew M. Tershakovec

Book ID: 119287867
Publisher: Elsevier
Year: 2010
Tongue: English
Weight: 41 KB
Volume: 4
Category: Article
ISSN: 1933-2874
DOI: 10.1016/j.jacl.2010.03.057

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of Ezetimibe Added to Atorvastat

Effects of Ezetimibe Added to Atorvastatin Versus Atorvastatin Up-Titration on Attainment of Single and Dual Levels for Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol, Apolipoprotein B, or High-Sensitivity C-Reactive Protein in Older Adults with High Coronary Heart Disease Risk

✍ Christian Constance; Ori Ben-Yehuda; Nanette K. Wenger; Franklin Zieve; Jianxin 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 50 KB

Achievement of specified low-density lip

Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study)

✍ Jennifer G. Robinson; Christie M. Ballantyne; Willa Hsueh; Jeffrey Rosen; Jianxi 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 469 KB